enbucrilate has been researched along with Koch's Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dere, O; Kolu, M; Kurtuluş, Ş; Yıldırım, IO; Yurttutan, N | 1 |
| Bou-Chacra, N; Clas, SD; Gao, Y; Löbenberg, R; Roa, W; Sarfraz, M; Shi, W | 1 |
| Burke, CT; Kang, SG; Lee, CT; Lee, JH; Yoo, DH; Yoon, CJ | 1 |
3 other study(ies) available for enbucrilate and Koch's Disease
| Article | Year |
|---|---|
Embolization with more diluted glue-lipiodol in patients with massive hemoptysis: single center experience results.
Topics: Bronchial Arteries; Bronchiectasis; Embolization, Therapeutic; Enbucrilate; Ethiodized Oil; Hemoptysis; Humans; Retrospective Studies; Treatment Outcome; Tuberculosis | 2022 |
Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Cyanoacrylates; Cytokines; Drug Carriers; Drug Liberation; Dynamic Light Scattering; Enbucrilate; Enzyme-Linked Immunosorbent Assay; Fluoroquinolones; Gelatin; Macrophages; Mice; Microscopy, Electron, Transmission; Moxifloxacin; Nanoparticles; Rifampin; Spectrophotometry, Ultraviolet; Tuberculosis | 2016 |
Bronchial and nonbronchial systemic artery embolization in patients with major hemoptysis: safety and efficacy of N-butyl cyanoacrylate.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortography; Aspergillosis; Bronchial Arteries; Bronchiectasis; Causality; Comorbidity; Embolization, Therapeutic; Enbucrilate; Female; Follow-Up Studies; Hemoptysis; Humans; Lung Neoplasms; Male; Mammary Arteries; Middle Aged; Recurrence; Retrospective Studies; Subclavian Artery; Tuberculosis; Young Adult | 2011 |